GNH USA

Europe — EMA

Levodopa/Carbidopa/Entacapone Eg (Carbidopa, Entacapone, Levodopa)

GNH USA supplies Levodopa/Carbidopa/Entacapone Eg (Levodopa/Carbidopa/Entacapone), a antiparkinson agent for Parkinson's disease.

Carbidopa, Entacapone, Levodopa

Request sourcing

1
Pack/s

What is Carbidopa, Entacapone, Levodopa?

Levodopa, the active ingredient in Levodopa/Carbidopa/Entacapone Eg, is a Levodopa/Carbidopa/Entacapone combination presented as a tablet for oral use. It treats Parkinson's disease in adults by restoring dopaminergic activity in the brain.

GNH USA supplies Levodopa/Carbidopa/Entacapone Eg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Carbidopa, Entacapone, Levodopa used for?

Levodopa/Carbidopa/Entacapone is used within the antiparkinson therapeutic class to manage motor symptoms of Parkinson's disease and related fluctuations. - Parkinson's disease: improves overall motor function and reduces rigidity and bradykinesia. - Parkinson's disease with motor fluctuations: prolongs the duration of levodopa effect and lessens OFF periods. - Adjunct therapy in early Parkinson's disease: enhances central dopaminergic activity when levodopa alone is insufficient.

What are the side effects of Carbidopa, Entacapone, Levodopa?

Levodopa/Carbidopa/Entacapone may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Dizziness: often related to orthostatic changes. - Headache: transient and usually self‑limiting. - Insomnia: difficulty initiating or maintaining sleep.

Serious or Rare Side Effects: - Dyskinesia: involuntary, erratic movements. - Hallucinations: visual or auditory perceptual disturbances. - Severe hypotension: marked drop in blood pressure with risk of fainting. - Neuroleptic malignant syndrome: rare but life‑threatening reaction. - Anaphylaxis: acute allergic response requiring immediate medical attention.

What precautions apply to Carbidopa, Entacapone, Levodopa?

Levodopa/Carbidopa/Entacapone requires careful monitoring to ensure safe use. - Blood pressure monitoring: watch for orthostatic hypotension, especially during dose titration. - Psychiatric assessment: observe for hallucinations, confusion, or mood changes. - Renal function evaluation: adjust therapy in patients with significant renal impairment. - Discontinuation caution: avoid abrupt cessation to prevent withdrawal or worsening of symptoms. - Elderly patients: start at low dose and titrate slowly due to increased sensitivity. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

What does Carbidopa, Entacapone, Levodopa interact with?

Levodopa/Carbidopa/Entacapone can interact with several drug classes.

Major Interactions (Avoid): - Non‑selective MAO inhibitors: risk of hypertensive crisis. - Selective MAO‑B inhibitors (e.g., selegiline): may cause severe hypertension. - Antipsychotics with strong dopamine blockade (e.g., haloperidol): reduce therapeutic effect.

Moderate Interactions (Monitor Closely): - Antihypertensive agents: additive blood‑pressure lowering effect. - SSRIs and SNRIs: potential for serotonin syndrome when combined with MAO‑B inhibitors. - Iron or antacid supplements: may decrease levodopa absorption; separate dosing by at least 2 hours.

Frequently asked questions

What is Levodopa/Carbidopa/Entacapone used for?+
Levodopa/Carbidopa/Entacapone is prescribed to manage the motor symptoms of Parkinson's disease, including rigidity, bradykinesia, and tremor, and to reduce OFF periods in patients who experience fluctuations in symptom control.
How does Levodopa/Carbidopa/Entacapone work?+
Levodopa is converted into dopamine in the brain, while carbidopa blocks its peripheral conversion, increasing central availability. Entacapone inhibits the COMT enzyme, extending levodopa’s plasma half‑life and enhancing dopaminergic stimulation.
What is the usual dose of Levodopa/Carbidopa/Entacapone?+
The specific dose and dosing schedule are determined by the prescribing clinician based on the individual’s disease severity, response to therapy, and tolerability. Patients should follow the prescriber’s instructions exactly.
Is Levodopa/Carbidopa/Entacapone safe during pregnancy or breastfeeding?+
Safety data in pregnancy and lactation are limited. The medication should only be used if the potential benefit justifies the potential risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.
How do I order Levodopa/Carbidopa/Entacapone from GNH USA?+
Enquiries are submitted via the product page on gnh-usa.com, where you specify the required quantity. GNH USA supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.
How does Levodopa/Carbidopa/Entacapone compare with standard levodopa therapy?+
Standard levodopa alone is rapidly metabolized, leading to shorter symptom control. Adding carbidopa prevents peripheral conversion, and entacapone further prolongs levodopa’s half‑life by inhibiting COMT, resulting in more stable plasma levels and fewer motor fluctuations.
What are the storage and handling requirements for Levodopa/Carbidopa/Entacapone?+
Store tablets at room temperature, below 25 °C, in the original blister pack or container. Protect from moisture and direct sunlight to maintain product stability.
How is Levodopa/Carbidopa/Entacapone administered?+
The medication is taken orally, usually with food to reduce gastrointestinal upset. Tablets should be swallowed whole with a full glass of water unless otherwise directed by the prescriber.
What are the most serious risks associated with Levodopa/Carbidopa/Entacapone?+
Serious risks include dyskinesia, severe hypotension, hallucinations, neuroleptic malignant syndrome, and rare allergic reactions such as anaphylaxis. Patients should be monitored closely for these events, especially during dose adjustments.
Who should not use Levodopa/Carbidopa/Entacapone?+
Patients with known hypersensitivity to levodopa, carbidopa, entacapone, or any excipients should avoid the product. It is also contraindicated in individuals taking non‑selective MAO inhibitors or those with a history of severe neuroleptic malignant syndrome.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Carbidopa, Entacapone, Levodopa
Route
Oral Use
Manufacturer
Eg Labo Laboratoires Eurogenerics
Origin
EU

Related products

Carbidopa-Entacapone-Levodopa Teva

Carbidopa-Entacapone-Levodopa Teva

Carbidopa, Entacapone, Levodopa

Teva Italia S.R.L.
EU
Corbilta

Corbilta

Carbidopa, Entacapone, Levodopa

Orion Corporation
EU
Corbilta

Corbilta

Carbidopa, Entacapone, Levodopa

Orion Corporation
EU
Corbilta

Corbilta

Carbidopa, Entacapone, Levodopa

Orion Corporation
EU